• Ribonuclease R (20 U/μL): Streamlining Circular RNA Enrichme

  2026-07-15

  Ribonuclease R (20 U/μL) empowers precise circular RNA enrichment by selectively digesting linear RNA, supporting advanced RNA structure studies and inflammation research. This article details optimized workflows, troubleshooting strategies, and insights from recent circRNA-inflammation discoveries—bridging bench protocols with next-generation biological insight.

• Absolute Quantification of Viable Vibrio cholerae in Seawate

  2026-07-15

  Yang et al. introduced a multiplex droplet digital PCR (ddPCR) method combined with propidium monoazide (PMA) treatment, enabling sensitive and specific absolute quantification of live toxigenic Vibrio cholerae O1/O139 in seawater. This assay improves detection accuracy over conventional qPCR, providing a reliable tool for environmental surveillance of cholera risks.

• CD28-ARS2 Axis Regulates PKM Splicing for CD8+ T Cell Flexib

  2026-07-14

  This study reveals a novel CD28-ARS2 signaling axis that drives alternative splicing of the PKM gene in CD8+ T cells, promoting metabolic flexibility and robust antitumor immunity. The findings clarify how immune costimulation reprograms glucose metabolism independently of the PI3K pathway, with significant implications for immunometabolic research and TCA cycle enzyme assays.

• BMX-IN-1: Advancing Translational Frontiers in BMX Kinase In

  2026-07-14

  This article presents a thought-leadership perspective for translational researchers, exploring the mechanistic and strategic potential of BMX-IN-1, a highly selective BMX kinase inhibitor. By weaving the latest mechanistic insights—including the role of BMX in lysosomal acidification and host-pathogen interactions—with practical experimental guidance, we highlight BMX-IN-1’s transformative value across cancer and infectious disease models. The discussion bridges cancer biology and tuberculosis research, provides actionable protocol parameters, and charts a forward-looking vision for BMX-targeted therapeutics, all with rigorous evidence integration and a strategic focus.

• Modeling Human Pacemaker Maturation with SAN-Plexus Assemblo

  2026-07-13

  This study introduces a human stem cell-derived tri-assembloid system integrating sinoatrial node, cardiac ganglionated plexus, and atrial organoids to model neuro-cardiac interactions underlying pacemaker maturation. The work enables functional dissection of neuron-to-pacemaker signaling and provides a platform for translational cardiovascular research.

• A40926: Dalbavancin Precursor for Precision Antibacterial As

  2026-07-13

  A40926, the natural precursor to dalbavancin, delivers superior potency and specificity for Gram-positive bacterial infection research, including MRSA and Neisseria gonorrhoeae. This guide translates benchmark studies and comparative workflows into actionable steps, optimizing in vitro and in vivo assays for reproducibility and high-yield data.

• Thiamet G: O-GlcNAcase Inhibitor for Bone and Brain Models

  2026-07-12

  Thiamet G uniquely enables researchers to modulate O-GlcNAcylation with nanomolar precision, unleashing new possibilities in disease modeling for neurodegeneration, oncology, and bone biology. Its robust solubility and cross-BBB activity make it the go-to O-GlcNAcase inhibitor for cell and animal workflows where precise control of post-translational modifications is essential.

• Pifithrin-α (PFTα): Unveiling p53 Inhibition in Neuroferropt

  2026-07-10

  Explore how Pifithrin-α, a leading p53 inhibitor, advances neurotoxicity and ferroptosis research beyond standard applications. This article highlights novel assay strategies and practical insights drawn from cutting-edge studies.

• Fumagillin: Applied Workflows for Methionine Aminopeptidase-

  2026-07-09

  Fumagillin, a potent methionine aminopeptidase-2 inhibitor, empowers reproducible inhibition of angiogenesis and precision antiparasitic protocols across cancer and aquaculture research. This guide deciphers experimental best practices, troubleshooting, and cross-domain innovations for maximizing assay reliability with APExBIO's Fumagillin.

• Brefeldin A in Cell Biology: Protocols, Applications & Tips

  2026-07-09

  Brefeldin A (BFA) is a gold-standard tool for dissecting ER stress, vesicle trafficking, and apoptosis induction in cancer and endothelial models. This guide integrates new biomarker insights, practical workflows, and troubleshooting tactics, empowering researchers to optimize BFA-driven experiments with APExBIO’s trusted reagent.

• Optimizing Calcium-Phosphate Transfection for HEK-293T Cells

  2026-07-08

  This article examines the recent optimization of the calcium-phosphate DNA transfection protocol for HEK-293T cells, focusing on the critical balance between plasmid DNA quantity and reaction volume. The findings offer a cost-effective alternative to commercial reagents, with implications for transient gene expression and large-scale recombinant protein production.

• AMG 487: Applied CXCR3 Antagonist Workflows in Macrophage St

  2026-07-08

  AMG 487 empowers researchers to precisely dissect CXCR3-driven macrophage polarization, offering robust inhibition across multiple chemokines and reliable modulation of inflammatory pathways. This guide translates state-of-the-art findings and validated protocols into actionable workflows, troubleshooting insights, and advanced applications for inflammation, autophagy, and acute lung injury models.

• Romidepsin (FK228): Applied HDAC Inhibition Workflows in Can

  2026-07-07

  Romidepsin (FK228) enables precision epigenetic modulation by selectively inhibiting HDAC1/2, unlocking synergistic therapeutic strategies in cancer research. This article delivers actionable workflows, troubleshooting tactics, and highlights the translational leap achieved by combining Romidepsin with PARP inhibitors in hepatocellular carcinoma models.

• Ionomycin Calcium Salt: Unlocking Advanced Calcium Signaling

  2026-07-07

  Ionomycin calcium salt, a high-precision calcium ionophore, empowers researchers to dissect calcium signaling pathways and apoptosis induction in cancer and secretory cell models. This guide details optimized protocols, experimental innovations, and troubleshooting insights, leveraging both APExBIO’s trusted reagent and the latest research on ribosome biogenesis and tumor cell survival.

• BMX-IN-1: Precision BMX Kinase Inhibition for Host-Pathogen

  2026-07-06

  Explore the unique capabilities of BMX-IN-1 as a selective BMX kinase inhibitor for investigating lysosomal acidification and apoptosis in cancer cells. This in-depth article reveals mechanistic insights and experimental strategies not covered in existing BMX-IN-1 literature.

16397 records 1/1094 page Next 12345 下5页 Last page